Hormone Replacement Therapy (HRT) for Women Comprehensive Panel
This HRT blood test panel checks key sex hormones, thyroid markers, and metabolic signals so you can monitor therapy response and safety over time.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a multi-marker lab panel designed for women who are starting, adjusting, or maintaining hormone replacement therapy (HRT). Instead of looking at one hormone in isolation, you get a coordinated set of results that helps you understand estrogen and progesterone exposure, androgen balance, pituitary signaling, thyroid overlap, and a few common metabolic “side signals” that can change how you feel on therapy.
Because HRT decisions depend on your symptoms, your medical history, and how your numbers fit together, this panel is best used to support clinician-directed care—not self-prescribing or chasing a single “perfect” value.
Do I need this panel?
You may benefit from an HRT-focused lab panel if you are considering HRT, recently started therapy, changed your dose or delivery method (patch, gel, oral, vaginal, or combination therapy), or you feel “off” and want to separate hormone-related effects from thyroid, iron, or metabolic issues that can mimic hormone symptoms.
This panel can be especially useful when your symptoms and your cycle timing do not line up neatly. For example, perimenopause can cause fluctuating estrogen and progesterone patterns, and PCOS (polycystic ovary syndrome) can shift androgen markers and binding proteins in ways that change how much hormone is actually available to tissues.
You may also want this panel if you are trying to avoid common pitfalls: assuming all symptoms are “low estrogen,” overlooking progesterone adequacy when using estrogen, missing thyroid overlap, or reacting to a single high or low result without checking related markers.
If you have new chest pain, shortness of breath, one-sided leg swelling, severe headache, sudden vision changes, heavy bleeding, or you are pregnant or could be pregnant, get urgent medical guidance before making any HRT changes.
Reference ranges and optimal targets can vary by lab method and by where you are in your cycle or menopause transition; your clinician may interpret trends across multiple draws more than a single snapshot.
Lab testing
Order the HRT comprehensive lab panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order an HRT monitoring lab panel and review the results in context. You can use this panel as a baseline before starting therapy, as a follow-up after a dose change, or as a periodic check-in to see whether your lab pattern matches how you feel.
Because this is a comprehensive panel, it helps you avoid “single-number” decisions. You can look at estrogen exposure alongside progesterone, androgen markers, pituitary signals (FSH/LH), and thyroid markers that often influence energy, mood, hair, and weight.
If you want help interpreting a multi-marker report, PocketMD can walk through patterns (not just isolated highs/lows), common confounders like cycle timing and medications, and what questions to bring to your prescribing clinician—especially when symptoms and labs disagree.
If you are tracking changes over time, repeating the same panel after a consistent interval and similar timing (relative to dosing and cycle) is often more informative than switching between different test bundles.
- Designed for trend tracking across multiple hormones (not a single analyte)
- Clear next-step questions for follow-up with your clinician
- PocketMD support for pattern-based interpretation
Key benefits of Hormone Replacement Therapy (HRT) for Women Comprehensive Panel testing
- Checks estrogen exposure alongside progesterone so you can evaluate balance rather than guessing from symptoms alone.
- Includes androgen and binding markers to help explain changes in libido, hair, acne, and energy on or off therapy.
- Adds pituitary signals (FSH/LH) that help frame where you are in the perimenopause-to-menopause transition.
- Screens thyroid overlap that can mimic “hormone imbalance” symptoms like fatigue, weight change, and mood shifts.
- Supports safer dose adjustments by looking for patterns that suggest under-treatment, overexposure, or inconsistent absorption.
- Helps you standardize follow-up testing by using the same panel for baseline and retests.
- Reduces misinformation risk by grounding HRT decisions in a multi-marker lab pattern instead of influencer protocols.
What is the Hormone Replacement Therapy (HRT) for Women Comprehensive Panel?
The Hormone Replacement Therapy (HRT) for Women Comprehensive Panel is a bundled blood test panel that measures multiple hormones and related biomarkers commonly used to guide and monitor HRT. The goal is not to “grade” you on one hormone level, but to show how several systems interact: ovarian/adrenal sex hormones, pituitary signaling, thyroid function, and a few metabolic markers that influence hormone availability and symptoms.
HRT monitoring is different from diagnostic testing for a single disease. Your results are interpreted in the context of your age, symptoms, menstrual status (cycling, perimenopausal, postmenopausal), the type of hormones you use (estradiol vs conjugated estrogens; micronized progesterone vs progestins), and how you take them (oral vs transdermal vs vaginal). Timing matters too—both cycle timing and timing relative to your last dose.
A comprehensive panel is helpful because hormones rarely move alone. For example, a “normal” total testosterone can still be functionally low if SHBG (sex hormone–binding globulin) is high, and thyroid changes can shift SHBG and alter free hormone fractions. Seeing the full pattern helps you and your clinician decide whether symptoms are more likely related to dosing, absorption, binding proteins, ovulatory status, thyroid function, or something outside hormones entirely.
This panel does not replace individualized medical care. It is a tool to support shared decision-making, especially when you are adjusting therapy or trying to understand why you feel better, worse, or unchanged on HRT.
What do my panel results mean?
Patterns that can look “low” on an HRT panel
A “low” pattern usually means one or more hormone categories are lower than expected for your situation: estradiol exposure may be low for your dose or delivery method, progesterone may be low relative to estrogen (common if progesterone is missed, under-dosed, or not used when indicated), or free androgens may be low due to high SHBG. You might also see pituitary markers (FSH/LH) remain high if you are postmenopausal or if ovarian signaling is low, even if you are using estrogen. If thyroid markers suggest hypothyroidism (for example, higher TSH with lower free T4), symptoms like fatigue, brain fog, constipation, and weight changes may be driven partly by thyroid rather than HRT dosing.
Patterns that often look “optimal” for monitoring
An “optimal” pattern is one where your results are internally consistent: estrogen markers align with your prescribed route and timing, progesterone exposure is appropriate for your uterus status and regimen, and androgen markers are not showing a mismatch between total levels and free availability (often reflected by SHBG). Pituitary markers may still be in a menopausal range depending on your stage, but the overall picture fits your symptoms and goals. Thyroid markers are typically stable and not signaling a separate driver of symptoms. In practice, optimal often means your numbers are steady across repeat tests taken at similar timing, and you feel well without side effects.
Patterns that can look “high” on an HRT panel
A “high” pattern can show up as higher-than-expected estradiol for your dose, a progesterone pattern that does not match your regimen, or androgen markers that suggest excess (or increased free fraction) that could contribute to acne, hair changes, or irritability. High SHBG can make total hormones look high while free hormones are not, and low SHBG can do the opposite—so the pattern matters more than one number. Thyroid patterns can also shift binding proteins and change how hormones circulate. If multiple markers point toward overexposure or inconsistent absorption (for example, a very high estradiol with symptoms of breast tenderness or headaches), it is a reason to review dosing, timing of the blood draw, and delivery method with your clinician rather than making abrupt changes.
Factors that influence your HRT panel results
Cycle timing (follicular vs luteal phase), perimenopause variability, and the exact timing of your blood draw relative to your last dose can change results substantially—especially with oral or short-acting formulations. Route of therapy matters: oral estrogen can affect liver-produced proteins (including SHBG) differently than transdermal estrogen, which can change free vs total hormone relationships. Body composition, insulin resistance, thyroid status, alcohol use, and certain medications (including thyroid hormone, glucocorticoids, anti-androgens, and some seizure medications) can shift hormone metabolism and binding. Finally, symptoms do not always track perfectly with serum levels; your clinician may use trends, dosing history, and your clinical response to interpret what the pattern means for you.
What’s included in this panel
- Dhea Sulfate
- Estradiol
- Estrogens, Total, Ia
- Estrone
- Fsh
- Igf 1, Lc/Ms
- Lh
- Pregnenolone, Lc/Ms
- Progesterone
- Progesterone, Lc/Ms
- Prolactin
- Sex Hormone Binding Globulin
- Testosterone, Free
- Testosterone, Total, Ms
- Z Score (Female)
- Z Score (Male)
Frequently Asked Questions
Do I need to fast for this HRT panel?
Fasting is often recommended if your panel includes glucose, insulin, or a lipid panel, because eating can change those results. If you cannot fast, you can still test, but tell your clinician and note the timing and what you ate so the metabolic markers are interpreted appropriately.
When should you test if you still have periods (perimenopause or cycling)?
Timing depends on what you are trying to answer. Many clinicians compare results to a consistent cycle window (often early follicular for baseline pituitary signals, or mid-luteal for progesterone exposure if you are ovulating). If your cycles are irregular, consistency matters more than perfection—choose a repeatable approach and document cycle day, bleeding pattern, and symptoms.
When should you draw labs relative to taking your HRT dose?
The best timing depends on the formulation. Some approaches aim for a “trough” (right before the next dose) to check minimum exposure, while others standardize a set number of hours after dosing. The key is to be consistent across retests and to record your last dose time and route so your clinician can interpret the pattern.
How do you interpret estradiol and progesterone together?
Your clinician typically looks for whether estrogen exposure fits your regimen and whether progesterone exposure is appropriate for your uterus status and symptom goals. A single estradiol value without progesterone context can be misleading, and progesterone interpretation differs depending on whether you are cycling, using cyclic progesterone, or are postmenopausal.
Why include testosterone and SHBG in a women’s HRT panel?
Androgens can influence libido, mood, muscle, hair, and skin. SHBG affects how much testosterone and estradiol are “free” (available) versus bound. Looking at total testosterone alone can miss a low free fraction (high SHBG) or an unexpectedly high free fraction (low SHBG).
Why include thyroid markers in an HRT monitoring panel?
Thyroid changes can mimic or amplify symptoms often blamed on sex hormones—fatigue, weight change, hair loss, mood shifts, constipation, and cold intolerance. Thyroid status can also influence binding proteins like SHBG, which changes how you interpret total vs free sex hormones.
Is it better to order this panel or pick individual hormone tests?
If you are actively adjusting therapy or your symptoms are complex, a panel can be more efficient because it captures related markers in one draw and helps avoid overreacting to a single number. Individual tests can make sense for narrow follow-ups (for example, rechecking one marker after a targeted change), but they are easier to misinterpret without the surrounding context.